Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KBBM (Korea Bio-Bank Management) is a specialized biotechnology organization focused on the systematic management and distribution of human bio-resources in South Korea. Operating under the Korea National Institute of Health (KNIH), it manages the Korea Biobank Network (KBN), which integrates bio-resources from various regional biobanks across the country. The company provides high-quality clinical data and biological samples, such as blood, tissue, and DNA, to researchers in academia and the pharmaceutical industry to support drug discovery and precision medicine. KBBM plays a critical role in the national infrastructure for life sciences by ensuring ethical standards and standardized protocols for bio-resource utilization. Its services are essential for large-scale genomic studies and the development of diagnostic tools and personalized therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KBBM.